Groningen, Netherlands

Mucosis B.v.


USPTO Granted Patents = 6

% Expired Patents = 83.3


Forward Citations = 4

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Cornelis Johannes Leenhouts (4 out of 15 patents)

silverMedal Petrus Josephus Marie Rottier (3 out of 4 patents)

bronzeMedal Bert Jan Haijema (3 out of 3 patents)

4.  Cornelis Alexander Maria De Haan (3 out of 3 patents)

5.  Ronald De Groot (2 out of 2 patents)

6.  Peter Wilhelmus Maria Hermans (2 out of 2 patents)

7.  Govert Johan Schouten (1 out of 17 patents)

8.  Maarten Leonardus Van Roosmalen (1 out of 2 patents)

9.  Berend Jan Bosch (1 out of 1 patent)


6 patents:

Company Overview
Mucosis B.V. is a clinical stage biotechnology company developing a revolutionary platform for needle-free vaccination. Using their patented Mimopath technology, they are able to develop highly effective mucosal vaccines for respiratory and other infectious diseases. Their goal is to provide safe, convenient, and cost-effective vaccines that can reach a broader population worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#11 in Groningen

#971 in Netherlands

Groningen, NL
Groningen, Netherlands
Forward Citations = 4

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mucosis B.v.. Retrieved from https://idiyas.com/company/mucosis-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…